Skip to main content

Animations

MJFF Publications

1601 - 1610 of 6568 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2024
  • Summary Details
    OPEN
    Title: Building national patient registries in Mexico: insights from the MexOMICS Consortium
    Journal Name: Frontiers in Digital Health
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fdgth.2024.1344103
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Leveraging sex-genetic interactions to understand brain disorders: recent advances and current gaps
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae192
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-48961-3
    Citation Count: 104
  • Summary Details
    OPEN
    Title: LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-018-0550-0
    Citation Count: 56
  • Summary Details
    OPEN
    Title: A novel extended form of alpha-synuclein 3′UTR in the human brain
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-018-0371-x
    Citation Count: 17
  • Summary Details
    OPEN
    Title: GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-23795-4
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-018-1023-6
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00036
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-018-0349-z
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Association of body mass index with rapid eye movement sleep behavior disorder in Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1388131
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.